KPJ Healthcare Clinches 15 Awards At GHAPAC 2025, Reaffirms Regional Leadership
KUALA LUMPUR, July 7 (Bernama) -- KPJ Healthcare Berhad reaffirmed its position as a regional leader in patient-centred, tech-driven care by emerging as the most awarded healthcare group at the 2025 GlobalHealth Asia-Pacific (GHAPAC) Awards, held recently in Bangkok, Thailand.
In a statement today, KPJ Healthcare announced it had clinched a total of 15 awards, reinforcing its standing as a regional leader in patient-centred, technology-driven care.
KPJ Healthcare president and managing director Chin Keat Chyuan said the recognition was a testament to the dedication and teamwork spirit across the group's network.
"Being recognised across such a wide range of specialties shows the depth of our clinical capabilities and our continuous efforts to improve.
"Guided by our purpose of Care for Life, we remain focused on delivering world-class care that is powered by innovation and compassion," he said in the statement.
Held alongside the GlobalHealth Asia-Pacific Summit and Conference, the GHAPAC Awards honoured excellence in clinical innovation, healthcare service delivery and medical technology across the region.
Seven KPJ hospitals were recognised across various clinical disciplines, reinforcing the group's leadership in specialised care and service excellence.
KPJ Tawakkal KL Specialist Hospital earned four major honours for Diagnostic Imaging Centre of the Year, Ear, Nose, and Throat (ENT) Service Provider of the Year, Urology Service Provider of the Year, and Brain and Spine Service Provider of the Year.
Damansara Specialist Hospital 2 picked up three key honours: Minimal Invasive Cardiac Surgery of the Year, Smart Hospital of the Year, and Cardiology Service Provider of the Year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
4 days ago
- The Sun
Malaysia leads global medical device regulatory reliance with China
KUALA LUMPUR: Malaysia has achieved a major milestone in global healthcare regulation with the launch of the Medical Device Regulatory Reliance Programme in partnership with China. The initiative, led by the Medical Device Authority Malaysia (MDA), marks a strategic leap in streamlining approvals for medical devices between the two nations. MDA chief executive Dr P. Muralitharan stated that the programme allows mutual recognition of pre-market approvals, significantly reducing processing times. Malaysian in-vitro diagnostic (IVD) devices will now qualify for China's Green Channel, while Chinese devices can utilise Malaysia's Verification Pathway, cutting approval periods to 60 and 30 working days, respectively. 'This collaboration eliminates regulatory duplication, speeds up market entry, and ensures faster patient access to advanced medical technologies,' Muralitharan said. 'It also solidifies Malaysia's reputation as a regional regulatory leader and boosts investor trust in our healthcare ecosystem.' The programme was unveiled at the Healthcare Information and Management Systems Society Asia-Pacific (HIMSS APAC) Health Conference & Exhibition 2025, following a memorandum of understanding signed between MDA and China's National Medical Products Administration (NMPA) in November 2023. Muralitharan encouraged industry players to engage with MDA for further details, emphasising the programme's role in fostering efficient and transparent healthcare regulation. The initiative officially begins on July 30, reinforcing Malaysia's commitment to global health innovation. - Bernama
Barnama
07-07-2025
- Barnama
KPJ Healthcare Clinches 15 Awards At GHAPAC 2025, Reaffirms Regional Leadership
Chief Marketing Officer of KPJ Healthcare Berhad, Sherene Azli (third, left) together with Team KPJ at the GlobalHealth Asia-Pacific Summit, Conference and Awards 2025. (Credit: KPJ Healthcare) KUALA LUMPUR, July 7 (Bernama) -- KPJ Healthcare Berhad reaffirmed its position as a regional leader in patient-centred, tech-driven care by emerging as the most awarded healthcare group at the 2025 GlobalHealth Asia-Pacific (GHAPAC) Awards, held recently in Bangkok, Thailand. In a statement today, KPJ Healthcare announced it had clinched a total of 15 awards, reinforcing its standing as a regional leader in patient-centred, technology-driven care. KPJ Healthcare president and managing director Chin Keat Chyuan said the recognition was a testament to the dedication and teamwork spirit across the group's network. "Being recognised across such a wide range of specialties shows the depth of our clinical capabilities and our continuous efforts to improve. "Guided by our purpose of Care for Life, we remain focused on delivering world-class care that is powered by innovation and compassion," he said in the statement. Held alongside the GlobalHealth Asia-Pacific Summit and Conference, the GHAPAC Awards honoured excellence in clinical innovation, healthcare service delivery and medical technology across the region. Seven KPJ hospitals were recognised across various clinical disciplines, reinforcing the group's leadership in specialised care and service excellence. KPJ Tawakkal KL Specialist Hospital earned four major honours for Diagnostic Imaging Centre of the Year, Ear, Nose, and Throat (ENT) Service Provider of the Year, Urology Service Provider of the Year, and Brain and Spine Service Provider of the Year. Damansara Specialist Hospital 2 picked up three key honours: Minimal Invasive Cardiac Surgery of the Year, Smart Hospital of the Year, and Cardiology Service Provider of the Year.
Borneo Post
06-07-2025
- Borneo Post
KPJ Kuching completes 1,111th robotic-assisted knee replacement procedure
KPJ Kuching medical director Dr Mahadhir Alhady Sulaiman (third left), Dr Lee, KPJ Kuching general manager Nor Azlina Jemain and KPJ Healthcare Berhad regional chief executive officer of East Malaysia Dr Kenny take a group photo with representatives from Zimmer and Johnson & Johnson to celebrate the 1,111th procedure. KUCHING (July 6): KPJ Kuching Specialist Hospital has completed its 1,111th robotic-assisted Total Knee Replacement (TKR), marking a key milestone in the hospital's commitment to precision surgery and improved patient outcomes. The hospital in a statement on Saturday said this latest procedure reflects the hospital's sustained focus on clinical excellence and its leadership in robotic-assisted joint replacement within KPJ Healthcare. The achievement builds on its recent recognition as Orthopaedic Service Provider of the Year — Asia-Pacific 2025 at the GlobalHealth Asia-Pacific Awards, which acknowledged its innovation, surgical outcomes and patient care standards. The procedures are performed using the ROSA® Knee System by Zimmer Biomet and the VELYS™ Robotic-Assisted Solution by Johnson & Johnson. These systems enhance surgical accuracy, support faster recovery, and improve long-term mobility—particularly for patients with chronic knee pain or advanced osteoarthritis. KPJ Healthcare president and managing director Chin Keat Chyuan said the milestone at KPJ Kuching reflects the strength of the group's network-wide focus on quality, innovation, and subspecialty development. 'Under the KPJ Health System, we are advancing high-impact clinical programmes that deliver better outcomes for our patients. 'Guided by our purpose of Care for Life, we remain committed to expanding access to technology-driven, personalised care across our hospitals,' he said. Meanwhile, Consultant Orthopaedic Surgeon and pioneer of robotic knee surgery at KPJ Kuching Dr Lee Woo Guan said each knee represents a person regaining their ability to move confidently and live independently. 'Robotic technology like ROSA and VELYS has helped us personalise each procedure with greater precision and consistency, which directly translates into better outcomes and faster recovery for our patients,' he said. He added that the robotic programme has enabled KPJ Kuching to achieve lower complication rates, shorter hospital stays, and higher levels of patient satisfaction. 'More patients are now opting for robotic-assisted procedures as part of their care journey, particularly for improved mobility and long-term joint health,' he said. KPJ Healthcare continues to strengthen its investment in robotic technology, clinical leadership, and sub-specialty services as part of its transformation journey. These efforts align with the Group's strategy to integrate care delivery, education, and research, as well as to raise the overall standard of care across Malaysia. For more information, visit
